Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Response Biomedical appoints Chinese distributor:

This article was originally published in Clinica

Executive Summary

Shanghai Kehua is to sell Canadian company Response Biomedical's RAMP cardiac marker tests for CK-MB, troponin I and myoglobin in China. Shanghai, the largest diagnostic reagent manufacturer and distributor in China, will also participate in the registration process. Response's RAMP system delivers highly accurate results in less than ten minutes, the company says. The total in vitro diagnostics market in China was estimated at $327 million in 1999 and this is expected to grow at a compound rate of 16.3% annually through 2005, according to Vancouver-based Response.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel